About 1 000 reports

Prevalence of hepatitis B infections are higher in the Asia Pacific and sub-Saharan African regions, with approximately one third of HBV prevalent cases residing in China.

  • Hepatitis
  • Pathology
  • World
  • Demand
  • Supply

Hepatitis C is a viral infection caused by Hepatitis C virus (HCV).

  • Hepatitis
  • Pathology
  • World
  • Demand
  • Supply

Therefore, low accessibility due to the high cost of hepatitis B treatment is one the biggest challenges for the goal aiming to eliminate hepatitis B during our forecast period.

  • Hepatitis
  • United States
  • World
  • Market Segment
  • Market Size
  • A: CAUSES OF HEPATITIS B
  • Hepatitis B Drugs Pipeline

Top ## players hold majority of stake in the market ##.

  • Hepatitis
  • World
  • Market Size
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • HEPATITIS DRUGS
  • Hepatitis Drugs Imports and Exports

Chapter III HEPATITIS DRUGS INDUSTRY ASSESSMENTS Nucleoside drugs are one important hepatitis drugs in China.

  • Hepatitis
  • China
  • Beijing Union Pharmaceutical Co., Ltd.
  • Livzon Group
  • Sichuan Medco Pharmaceutical Stock Co., Ltd.
  • HEPATITIS DRUGS
  • Hepatitis Drugs Industry Structure

Chapter III HEPATITIS DRUGS INDUSTRY ASSESSMENTS Nucleoside drugs are one important hepatitis drugs in China.

  • Hepatitis
  • China
  • Beijing Union Pharmaceutical Co., Ltd.
  • Livzon Group
  • Sichuan Medco Pharmaceutical Stock Co., Ltd.

Hepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 ##.

  • Hepatitis
  • Pathology
  • Therapy
  • World
  • Market Size
  • Hepatitis Drugs Sales Volumes
  • Other Hepatitis Drugs

INTRODUCTION Chapter I Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) Chapter I INTRODUCTION The current market for hepatitis drugs in China is growing rapidly.

  • Hepatitis
  • China
  • Beijing Union Pharmaceutical Co., Ltd.
  • GlaxoSmithKline Tianjin Co., Ltd.
  • Sichuan Medco Pharmaceutical Stock Co., Ltd.
  • Hepatitis B Development Pipeline, by Phase
  • Promising Drugs in Development for Hepatitis B

Hepatitis B: Competitive Landscape to 2027 Report Code: GDHC##CL Published: May 2019 Healthcare TABLE OF CONTENTS ##.

  • Hepatitis
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Ionis Pharmaceuticals, Inc.

Global Hepatitis Diagnostic Testing Market, 2019-2023: US, Europe, Japan Global Hepatitis Diagnostic Testing Market, 2019-2023: US, Europe, Japan The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain,

  • Hepatitis
  • Europe
  • Japan
  • United States
  • Demand

Global Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Emerging Opportunities in the US, Europe, Japan Global Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Emerging Opportunities in the US, Europe, Japan The report presents a detailed analysis of the

  • Hepatitis
  • Europe
  • Japan
  • United States
  • Demand

Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.

  • Hepatitis
  • Pathology
  • World
  • Demand
  • Market Shares

The 2020-2025 World Outlook for Hepatitis C Virus (HCV) Therapeutics ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Hepatitis
  • Pathology
  • World
  • Demand

Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.

  • Hepatitis
  • Pathology
  • World
  • Demand
  • Market Shares

Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.

  • Hepatitis
  • Europe
  • Japan
  • United States
  • Demand
  • Products in Clinical Development for Hepatitis C
  • Hepatitis C Development Pipeline, by Phase

Report Code: GDHC##CL Published: June 2018 Hepatitis C: Competitive Landscape to 2026 Healthcare TABLE OF CONTENTS ##.

  • Drug Development
  • Hepatitis
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.

Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.

  • Hepatitis
  • Europe
  • Japan
  • United States
  • Demand

Hoffmann Roche ##. ##. ## Diasorin S. p. A ##. ##. ## bioMeriuex ##. ##. ## Hologic Inc ##. ##. ## Bio-Rad Laboratories Inc List of Figures Figure ##: Global: Hepatitis Diagnostic Tests Market: Major Drivers and Challenges Figure ##: Global: Hepatitis Diagnostic Tests Market: Sales Value (in Bil

  • Hepatitis
  • Pathology
  • World
  • Demand

Market Spotlight: Hepatitis B CONTENTS ## OVERVIEW ## KEY TAKEAWAYS ## DISEASE BACKGROUND ## TREATMENT ## Nucleos(t)ide analogs ## Interferons ## EPIDEMIOLOGY ## Hepatitis B in the US, China, Japan, and five major EU markets ## MARKETED DRUGS ## PIPELINE DRUGS ## RECENT EVENTS AND ANA

  • Hepatitis
  • China
  • United States
  • World
  • Market Description

Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.

  • Health Services
  • Hepatitis
  • Pathology
  • World
  • Demand

Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.

  • Hepatitis
  • Europe
  • Japan
  • United States
  • Demand
  • TREATMENT GUIDELINES FOR HEPATITIS C
  • LEADING TREATMENTS FOR HEPATITIS C, 2016

VIRAL HEPATITIS; ## (##):##-##.

  • Hepatitis
  • Market Size
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.

Hepatitis C Global Clinical Trials Review, H##, 2017 Table of Contents ## List of Tables ## List of Figures ## Report Guidance ## GlobalData Clinical Trials Report Coverage ## Clinical Trials by Region ## Clinical Trials and Average Enrollment by Country ## Top Five Countries Contributing to Clinic

  • Clinical Trial
  • Drug Development
  • Hepatitis
  • Pathology
  • World

Hepatitis Diagnostic Test Market Size, Outlook and Growth Opportunities, 2019- 2025 ##.

  • Hepatitis
  • APAC
  • World
  • Forecast
  • Market Size

The Hepatitis E pipeline guide presents information on all active drugs currently being developed for Hepatitis E.

  • Hepatitis
  • Pathology
  • World
  • Demand

The Hepatitis A pipeline guide presents information on all active drugs currently being developed for Hepatitis A.

  • Hepatitis
  • Pathology
  • World

The Hepatitis D(HDV) pipeline guide presents information on all active drugs currently being developed for Hepatitis D(HDV).

  • Hepatitis
  • Pathology
  • World

Emerging Diagnostic Technologies ##.

  • Hepatitis
  • Pathology
  • Market Shares
  • depicts the treatment patterns of hepatitis C in India. The hepatitis C prevalence
  • HEPATITIS C THERAPEUTICS MARKET, GLOBAL, PIPELINE, 2017

CERTAIN-##: Efficacy and Safety of Glecaprevir/ Pibrentasvir in Japanese Patients With Chronic Genotype ## Hepatitis C Virus Infection With and Without Cirrhosis.

  • Hepatitis
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Roche Group
  • Hepatitis C
  • HEPATITIS B

Abbott Diagnostics is one of the leading vendors in the global hepatitis B and C diagnostics market.

  • Hepatitis
  • World
  • Market Size
  • QIAGEN N.V.
  • Roche Group